WHO ICTRP trial
The combination of Elacestrant and exemestane for patients with pretreated…
CTIS2024-519792-25-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-519792-25-00 |
|---|---|
| Public title | The combination of Elacestrant and exemestane for patients with pretreated metastatic breast cancer expressing hormone receptors and non-expressing HER2, with lesions which uptake [18F]FES-avid (COMBINE): a proof-of-concept phase 2 clinical trial |
| Scientific title | Elacestrant and exemestane for patients with pretreated HR+/HER2- metastatic breast cancer and [18F]-FES-avid lesions (COMBINE): a proof-of-concept phase 2 clinical trial - UID 4270 |
| Primary sponsor | Istituto Europeo Di Oncologia S.r.l. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Italy |
| Conditions | Metastatic hormone receptor-positive/HER2-negative breast cancer MedDRA version: 24.0Level: PTClassification code: 10085481Term: Hormone receptor positive HER2 negative breast cancer Class: 100000004864 MedDRA version: 27.0Level… |
| Interventions | Product Name: EstroTep 500 MBq/mL, solution injectable, Product Code:PRD11510725, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: ELACESTRANT, Product Code:SUB184531, Pharmaceutical Form… |
| Registration date | Jul 15, 2025 |
| Target size | 26 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: